Fusion Antibodies are attending Antibody Engineering & Therapeutics Asia

Fusion Antibodies are pleased to be attending Antibody Engineering & Therapeutics Asia on 26-28th February 2019 in Tokyo.

Taking place at the Hilton Tokyo Bay Hotel, Tokyo, Japan on 26-28th February 2019,  Antibody Engineering & Therapeutics Asia is the only event in Asia providing the latest science, technology and partners to accelerate antibody and  protein therapies, ADCs, Bispecifics and immune-oncology. The event plays host to world-renowned scientists sharing the latest technologies, R&D and clinical data to fast track your next-generation therapeutics towards commercial success, so it is an event not to be missed!

Get in touch with us to organise a meeting with our CEO Paul Kerr and our Business Development Executive Yang Yang , tell us about your projects needs and hear all about how Fusion Antibodies pioneering services can help you.